Vericel CORP Schedule 13G passive stakes

Soleus Capital Master Fund, L.P. and associated entities have reported beneficial ownership of 2.8% of Vericel Corp. common stock as of June 30, 2026.

Vanguard Capital Management has reported beneficial ownership of 2,603,128 shares of Vericel Corp common stock, representing 5.11% of the class, as of March 31, 2026.

Soleus Capital Master Fund and related entities have reported a 5.0% passive beneficial ownership in Vericel Corp's common stock.

The Vanguard Group has filed an amendment to its Schedule 13G, reporting zero beneficial ownership in Vericel Corp common stock following an internal organizational realignment.

Brown Capital Management, LLC has filed an amendment to its Schedule 13G, disclosing a 3.87% beneficial ownership in Vericel Corporation's common stock.

State Street Corporation has reported a 5.6% beneficial ownership stake in Vericel Corp, holding 2,807,242 shares of common stock as of September 30, 2025.

Brown Capital Management, LLC has filed an amended Schedule 13G, reporting a beneficial ownership of 6.56% of Vericel Corporation's common stock as of December 31, 2024.

BlackRock, Inc. has filed an Amendment No. 7 to its Schedule 13G, reaffirming its passive beneficial ownership of 15.1% of Vericel Corp's common stock.

Brown Capital Management, LLC has filed an amended Schedule 13G, disclosing a 6.56% beneficial ownership stake in Vericel Corporation as of December 31, 2024.